Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins

Clinical Genetics

Volumn 62, Issue 2, 2002, Pages 151-156

  Mew, N Ah ^a   Hamel, N ^a,b   Galvez, M ^a   Al Saffar, M ^a   Foulkes, William D ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

BRCA1; Chile; Genes; Haplotype; Jews

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; BIOASSAY; BREAST CANCER; CHILE; CONTROLLED STUDY; ETHNOLOGY; FAMILY STUDY; FEMALE; FOUNDER EFFECT; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; HAPLOTYPE; HUMAN; JEW; POPULATION GENETICS; PREMENOPAUSE; PRIORITY JOURNAL; SHORT SURVEY;

ADULT; CHILE; FEMALE; GENES, BRCA1; HAPLOTYPES; HUMANS; JEWS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; SEQUENCE DELETION;

STAPHYLOCOCCUS PHAGE 187;

EID: 0036705777     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620208.x     Document Type: Short Survey

References (23)

1. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994: 266 (5182): 66-71.
2. Struewing JP, Abeliovich D, Peretz T et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in the Ashkenazi Jewish individuals. Nat Genet 1995: 11 (2): 198-200.
3. Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Godwin AK. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 1996: 58 (6): 1166-1176.
4. Neuhausen SL, Mazoyer S, Friedman L et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 1996: 58 (2): 271-280.
5. Diez O, Osorio A, Robledo M et al. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients. Br J Cancer 1999: 79 (7-8): 1302-1303.
6. Diez O, Domenech M, Alonso MC et al. Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population. Hum Genet 1998: 103 (6): 707-708.
7. Moslehi R, Chu W, Karlan B et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 2000: 66 (4): 1259-1272.
8. Bar-Sade RB, Kruglikova A, Modan B et al. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet 1998: 7 (5): 801-805.
9. Bar-Sade RB, Theodor L, Gak E et al. Could the 185delAG BRCA1 mutation be an ancient Jewish mutation? Eur J Hum Genet 1997: 5 (6): 413-416.
10. Abeliovich D, Kaduri L, Lerer I et al. The founder mutation 185delAG and 5382InsC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early onset breast cancer patients among Ashkenazi women. Am J Hum Genet 1997: 60 (3): 505-514.
11. Sher C, Sharabini-Gargir L, Shohat M. Breast cancer and BRCA1. New Engl J Med 1996: 334 (18): 1199.
12. Menczer J, Theodor L, Friedman E. BRCA1 185delAG mutation in a non-Ashkenazi Jewish woman with early-onset breast and ovarian cancer. Am J Obstet Gynecol 1997: 176 (3): 731.
13. Ostrer H. A genetic profile of contemporary Jewish populations. Nat Rev Genet 2001: 2 (11): 891-898.
14. Bernardi P, Fiering N. The Jews and the Expansion of Europe to the West. New York: Berghan, 2001: 1450-1800.
15. Liebman SB. The Inquisitors and the Jews in the New World. Florida: University of Miami, 1974.
16. Ellis NA, Ciocci S, Proytcheva M, Lennon D, Groden J, German J. The Ashkenazic Jewish Bloom syndrome mutation blmAsh is present in non-Jewish Americans of Spanish ancestry. Am J Hum Genet 1998: 63 (6): 1685-1693.
17. Nuno-Arana I, Garcia-Garcia VA, Espejo-Plascencia I, Ramos-Zavala AL, Rivera H. An intracranial carcinoma in a Mexican woman with Bloom syndrome. Ann Genet 2000: 43 (1): 55-57.
18. Rivera H, Garcia-Cruz D, Vaca G, Moller M, Ramos-Zepeda R, Cantu JM. Bloom syndrome in a Mexican mestizo girl. Ann Genet 1986: 29 (1): 39-41.
19. Berg MA, Peoples R, Perez-Jurado L et al. Receptor mutations and haplotypes in growth hormone receptor deficiency: a global survey and identification of the Ecuadorean E180splice mutation in an oriental Jewish patient. Acta Paediatr Suppl 1994: 399: 112-114.
20. Lee HS, Sambuughin N, Cervenakova L et al. Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. Am J Hum Genet 1999: 64 (4): 1063-1070.
21. Trincado P, Fardella C, Mayerson D et al. Prevalencia de la deleción 185AG del gen BRCA1 en mujeres chilenas con cáncer de mama. Rev Med Chile 1999: 127 (1): 19-22.
22. Wilson JF, Weale ME, Smith AC et al. Population genetic structure of variable drug response. Nat Genet 2001: 29: 265-269.
23. Risch HA, McLaughlin JR, Cole DE et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001: 68 (3): 700-710.